Psyence Biomedical Ltd. Calls Special Shareholder Meeting

Ticker: PBMWW · Form: 6-K · Filed: Mar 31, 2025 · CIK: 1985062

Sentiment: neutral

Topics: shareholder-meeting, corporate-action, filing

TL;DR

Psyence Biomedical calling a shareholder meeting April 16th - expect news.

AI Summary

Psyence Biomedical Ltd. filed a Form 6-K on March 31, 2025, announcing a Special Meeting of Shareholders scheduled for April 16, 2025. The filing includes the notice of this meeting, the record date, and the form of proxy. The company is a foreign private issuer and will file its annual reports under Form 20-F.

Why It Matters

This filing indicates upcoming corporate actions and decisions that could impact the company's strategic direction and shareholder value.

Risk Assessment

Risk Level: low — This is a routine filing announcing a shareholder meeting, not indicating significant financial or operational changes.

Key Players & Entities

FAQ

What is the purpose of the Special Meeting of Shareholders?

The filing does not explicitly state the purpose, but it includes the notice of the meeting, record date, and proxy form, suggesting important shareholder decisions will be made.

When is the Special Meeting of Shareholders scheduled to take place?

The Special Meeting of Shareholders is scheduled to be held on April 16, 2025.

What type of annual report filing does Psyence Biomedical Ltd. use?

Psyence Biomedical Ltd. indicates it files its annual reports under cover of Form 20-F.

What is the filing date of this Form 6-K?

This Form 6-K was filed on March 31, 2025.

Where is Psyence Biomedical Ltd. headquartered?

Psyence Biomedical Ltd. is headquartered at 121 Richmond Street West Penthouse Suite 1300, Toronto, Ontario M5H 2K1.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on March 31, 2025 regarding PSYENCE BIOMEDICAL LTD. (PBMWW).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing